Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Chirurgia Italiana|November 29, 2001
Colorectal endometriosis: aggressive surgical management and practical considerations in a patient with advanced diseaseL Succi, G S Urrico, A Politi, et al.
Gynecologic Oncology|February 1, 2011
Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experienceG Mangili, C Sigismondi, D Lorusso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2009
Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) GroupD Lorusso, G Ferrandina, S Pignata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2016
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 studyG Mangili, C Sigismondi, D Lorusso, et al.
Oncology|November 29, 2008
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trialS Pignata, G Scambia, A Savarese, et al.
Neuropediatrics|January 4, 2005
Fetal cells in maternal blood: a six-fold increase in women who have undergone amniocentesis and carry a fetus with Down syndrome: a multicenter studyE Falcidia, E Parano, A Grillo, et al.
Reproductive Biomedicine Online|September 4, 2008
Expression analysis of TFIID in single human oocytes: new potential molecular markers of oocyte qualityC Di Pietro, M Vento, M Ragusa, et al.
Journal of Endocrinological Investigation|October 26, 2012
High prevalence of thyroid dysfunction in pregnant womenM Altomare, S La Vignera, P Asero, et al.
Scientific Reports|January 16, 2019
Identification of extracellular vesicles and characterization of miRNA expression profiles in human blastocoel fluidR Battaglia, S Palini, M E Vento, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2023
Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trialE Pujade-Lauraine, F Selle, G Scambia, et al.
Pageof 3